Skip to main content
Journal cover image

TuNa-AI: A Hybrid Kernel Machine To Design Tunable Nanoparticles for Drug Delivery.

Publication ,  Journal Article
Zhang, Z; Xiang, Y; Laforet, J; Spasojevic, I; Fan, P; Heffernan, A; Eyler, CE; Wood, KC; Hartman, ZC; Reker, D
Published in: ACS Nano
September 23, 2025

Artificial intelligence (AI) has the potential to transform nanoparticle development for drug delivery; however, existing strategies typically optimize either material selection or component ratios in isolation. To enable simultaneous optimization of both, we integrated an automated liquid handling platform with machine learning to systematically explore the nanoparticle formulation space. A data set comprising 1275 distinct formulations (spanning drug molecules, excipients, and synthesis molar ratios) was generated, resulting in a 42.9% increase in successful nanoparticle formation through composition optimization. We developed a bespoke hybrid kernel machine that couples molecular feature learning with relative compositional inference, enhancing the modeling of formulation outcomes across chemical spaces. This hybrid kernel significantly improved prediction performance across three kernel-based algorithms, with a support vector machine (SVM) achieving superior performance when using our kernel compared to standard kernels and outperforming all other machine learning architectures, including transformer-based deep neural networks. Using SVM-guided predictions, we successfully formulated the difficult-to-encapsulate venetoclax with optimized taurocholic acid ratios, yielding enhanced in vitro efficacy against Kasumi-1 leukemia cells. In a second case study, our AI-guided platform reduced excipient usage by 75% in a trametinib formulation while preserving the in vitro efficacy and in vivo pharmacokinetics relative to the standard formulation. Taken together, this study establishes a generalizable framework that combines robotic experimentation, kernel machine learning, and experimental validation to accelerate nanoparticle composition optimization for drug delivery.

Duke Scholars

Published In

ACS Nano

DOI

EISSN

1936-086X

Publication Date

September 23, 2025

Volume

19

Issue

37

Start / End Page

33288 / 33296

Location

United States

Related Subject Headings

  • Support Vector Machine
  • Nanoscience & Nanotechnology
  • Nanoparticles
  • Mice
  • Machine Learning
  • Humans
  • Drug Delivery Systems
  • Cell Line, Tumor
  • Artificial Intelligence
  • Antineoplastic Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zhang, Z., Xiang, Y., Laforet, J., Spasojevic, I., Fan, P., Heffernan, A., … Reker, D. (2025). TuNa-AI: A Hybrid Kernel Machine To Design Tunable Nanoparticles for Drug Delivery. ACS Nano, 19(37), 33288–33296. https://doi.org/10.1021/acsnano.5c09066
Zhang, Zilu, Yan Xiang, Joe Laforet, Ivan Spasojevic, Ping Fan, Ava Heffernan, Christine E. Eyler, Kris C. Wood, Zachary C. Hartman, and Daniel Reker. “TuNa-AI: A Hybrid Kernel Machine To Design Tunable Nanoparticles for Drug Delivery.ACS Nano 19, no. 37 (September 23, 2025): 33288–96. https://doi.org/10.1021/acsnano.5c09066.
Zhang Z, Xiang Y, Laforet J, Spasojevic I, Fan P, Heffernan A, et al. TuNa-AI: A Hybrid Kernel Machine To Design Tunable Nanoparticles for Drug Delivery. ACS Nano. 2025 Sep 23;19(37):33288–96.
Zhang, Zilu, et al. “TuNa-AI: A Hybrid Kernel Machine To Design Tunable Nanoparticles for Drug Delivery.ACS Nano, vol. 19, no. 37, Sept. 2025, pp. 33288–96. Pubmed, doi:10.1021/acsnano.5c09066.
Zhang Z, Xiang Y, Laforet J, Spasojevic I, Fan P, Heffernan A, Eyler CE, Wood KC, Hartman ZC, Reker D. TuNa-AI: A Hybrid Kernel Machine To Design Tunable Nanoparticles for Drug Delivery. ACS Nano. 2025 Sep 23;19(37):33288–33296.
Journal cover image

Published In

ACS Nano

DOI

EISSN

1936-086X

Publication Date

September 23, 2025

Volume

19

Issue

37

Start / End Page

33288 / 33296

Location

United States

Related Subject Headings

  • Support Vector Machine
  • Nanoscience & Nanotechnology
  • Nanoparticles
  • Mice
  • Machine Learning
  • Humans
  • Drug Delivery Systems
  • Cell Line, Tumor
  • Artificial Intelligence
  • Antineoplastic Agents